Neurogene Inc.
@neurogeneinc
Neurogene is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.
ID: 1093532672125657089
http://www.neurogene.com 07-02-2019 15:31:20
201 Tweet
589 Followers
207 Following
We are pleased to share the first patient was dosed in the high-dose cohort of NGN-401 gene therapy trial for #Rettsyndrome and has been well-tolerated thus far. We'll share updated interim safety data from the low-dose cohort International Rett Syndrome Foundation ASCEND Summit. bit.ly/3XsvGST
Today, we joined the Russell 3000® Index as part of FTSE Russell, An LSEG Business #RussellRecon. Learn more here: bit.ly/4eMgh69
Thank you Nasdaq Exchange for hosting us for an amazing morning ringing today’s opening bell! Watch the ceremony here: bit.ly/4dufaXu $NGNE #NasdaqListed
🥼 Neurogene Inc is on a mission to improve the lives of patients and families devastated by rare neurological diseases. 🧬 The medicine Neurogene Inc. is creating has the potential to change the way these disorders are treated. 🔔 Proud to be your partner $NGNE! #NasdaqListed
Tune in today at 11:00 a.m. ET to watch our Founder and Chief Executive Officer, Dr. Rachel McMinn, in a fireside chat at the H.C. Wainwright & Co. 26th Annual Global Investment Conference. A link to the webcast is available here: bit.ly/4dWYFDE #HCWainwrightGlobal